Fas-Related Apoptosis of Peritoneal Fluid Macrophages in Endometriosis Patients: Understanding the Disease
Table 2
Soluble form of Fas (sFas) antigen concentration in peritoneal fluid and percentage of macrophages expressing CD95 (CD95+) and HLA-DR (HLA-DR+) antigens.
Endometriotic patients ()
Stage I ()
Stage II ()
Stage III/IV ()
Reference group ()
CD95+ macrophages (%)
20.1 ± 15.7
17.6 ± 15.2
16.6 ± 7.8
37.4 ± 19.8
6.6 ± 10.1
MFI of CD95 antigen on macrophages
101 ± 17.5 NS
101.5 ± 13.5 NS
108.9 ± 17.8 NS
90.7 ± 25.6 NS
98.9 ± 24.2
HLA-DR+ macrophages (%)
85.4 ± 7.3
85.6 ± 7.1
84.0 ± 7.7
89.0 ± 7.1 NS
62.2 ± 31.1
MFI of HLA-DR antigen on macrophages
148.0 ± 20.4
146.9 ± 14.1 NS
145.8 ± 14.6 NS
156.6 ± 39.3 NS
129.3 ± 28.0
sFas concentration in PF (U/l)
9.0 ± 7.4 NS
4.7 ± 3.1 NS
9.9 ± 7.4
16.2 ± 13.1
5.5 ± 4.4
Statistically significant in relation to the reference group. NS: statistically nonsignificant.
